Xeris Biopharma Holdings, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Xeris Biopharma Holdings, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2023.
  • Xeris Biopharma Holdings, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $4.23M, a 44.6% increase year-over-year.
  • Xeris Biopharma Holdings, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $13.2M, a 18.1% increase year-over-year.
  • Xeris Biopharma Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $10.7M, a 11.9% decline from 2022.
  • Xeris Biopharma Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $12.2M, a 6.85% increase from 2021.
  • Xeris Biopharma Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $11.4M, a 37.6% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $10.7M -$1.44M -11.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-06
2022 $12.2M +$779K +6.85% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-06
2021 $11.4M +$3.11M +37.6% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-06
2020 $8.27M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.